77.53BATS BZX Real-Time Price As of 3:27pm ET |  -0.31 / -0.40%Today’s Change | 62.43 Today|||52-Week Range 84.49 | +6.03% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $8.4B |
Company Description
PerkinElmer, Inc. (United States) engages in the provision of products, services, and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. It operates through the Discovery and Analytical Solutions, and Diagnostics segments. The Discovery and Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
Employees
Shareholders
| Mutual fund holders | 65.35% |
| Other institutional | 30.81% |
| Individual stakeholders | 2.33% |
Top Executives
| Robert F. Friel | Chairman, President & Chief Executive Officer |
| Tajinder Vohra | Senior Vice President-Global Operations |
| James M. Mock | Chief Financial Officer & Senior Vice President |
| James L. Corbett | Senior Vice President & President-Human Health |
| Deborah Butters | Chief Human Resources Officer & SVP |
-0.31 / -0.40%
